Figure 3
Forest plots regarding inflammatory cytokines and chemokines showing the effect of: (A) PI3K pan-inhibitors on total IgE; (B) PI3K-δ inhibitors on total IgE; (C) PI3K pan-inhibitors on IL-4; (D) PI3K-δ inhibitors on IL-4; (E) PI3K pan-inhibitors on IL-5; (F) PI3K-δ inhibitors on IL-5; (G) PI3K pan-inhibitors on IL-13; (H) PI3K-δ inhibitors on IL-13; (I) PI3K pan-inhibitors on eotaxin; (J) PI3K-δ inhibitors on eotaxin; (K) PI3K pan-inhibitors on IFN-γ; (L) PI3K pan-inhibitors on TGF-β; (M) PI3K pan-inhibitors on IL-6; (N) PI3K-δ inhibitors on IL-6; (O) PI3K pan-inhibitors on TNF-α; (P) PI3K-δ inhibitors on TNF-α; (Q) PI3K pan-inhibitors on IL-1β; (R) PI3K-δ inhibitors on IL-1β; (S) PI3K pan-inhibitors on VEGF; (T) PI3K-δ inhibitors on VEGF.
